바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.65 No.6
Citation Share

A Case of Tuberculosis-associated Hemophagocytic Syndrome during Antituberculosis Medication for Tuberculous Pericarditis

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2008, v.65 no.6, pp.522-526










& (2008). A Case of Tuberculosis-associated Hemophagocytic Syndrome during Antituberculosis Medication for Tuberculous Pericarditis. Tuberculosis & Respiratory Diseases, 65(6), 522-526.
  • Downloaded
  • Viewed
PDF Download

Abstract

A 63-year old woman was admitted to our hospital for an evaluation of thrombocytopenia. She had been diagnosed with tuberculous pericarditis three months earlier in a local clinic and treated with anti-tuberculosis medication. Two months later, thrombocytopenia developed. The medication was subsequently stopped because it was suspected that the anti-tuberculosis medication, particularly rifampin, might have caused the severe platelet reduction. However, the thrombocytopenia was more aggravated. A bone marrow biopsy was performed, which showed moderate amounts of histiocytes with active hemophagocytosis. This finding strongly suggested that the critical thrombocytopenia had been caused by hemophagocytic syndrome, not by the side effects of the anti-tuberculosis medication. Furthermore, the development of hemophagocytosis might have been due to an uncontrolled tuberculosis infection and its associated aberrant immunity. Therefore, she was started with both standard anti-tuberculosis medication and chemotherapy using etoposide plus steroid. One month after the initiation of treatment, the thrombocytopenia had gradually improved and she was discharged in a tolerable condition. At the third month of the follow-up, her platelet level and ferritin, the activity marker of hemophagocytic syndrome, was within the normal range

keywords
Hemophagocytic syndrome, Tuberculosis pericarditis, Antituberculosis medication

Reference

1.

Scott R, (1939) Histiocytic medullary reticulosis, Lancet

2.

Mills MJ, (1982) Post-viral haemophagocytic syndrome, J R Soc Med

3.

Risdall RJ, (1984) Bacteria-associated hemophagocytic syndrome, Cancer

4.

Campo E, (1986) Tuberculosis-associated hemophagocytic syndrome: a systemic process, Cancer

5.

Brastianos PK, (2006) Tuberculosis-associated haemophagocytic syndrome, Lancet Infect Dis

6.

Yang CW, (1996) Tuberculosis-associated hemophagocytic syndrome in a hemodialysis patient: case report and review of the literature, Nephron

7.

Park SS, (1996) A case of pancytopenia associated with disseminated tuberculosis and reactive histiocytic hemophagocytic syndrome, Korean J Hematol

8.

Yu SE, (2002) case of tuberculosis-associated hemophagocytic syndrome in renal transplant recipient, Korean J Nephrol

9.

Shin BC, (2004) Hemophagocytic syndrome associated with bilateral adrenal gland tuberculosis, Korean J Intern Med

10.

Larroche C, (2004) Pathogenesis of hemophagocytic syndrome (HPS), Autoimmun Rev

11.

Rouphael NG, (2007) Infections associated with haemophagocytic syndrome, Lancet Infect Dis

12.

Jain D, (2004) Pancytopenia due to extensive hemophagocytosis following anti-tubercular treatment, Am J Hematol

Tuberculosis & Respiratory Diseases

e-Submission OA Policy